Q2 2015

Filed Aug 10, 2015 · 10-Q · 41 days after period end · 0001437749-15-015305

Q2 2015 · 10-Q

Revenue

$39.84K

+89.0% vs Q2 2014

Net Income

-$1.82M

N/M vs Q2 2014

EPS Diluted

-$0.02

N/M vs Q2 2014

Gross Profit$7,928−9.1%

Operating Income

Same quarter

Metric	Q2 2015	Q2 2014	Q2 2013	Q2 2012
Revenue	$39.84K	$21.09K	$119.98K	$13.84K
Net Income	-$1.82M	-$826.46K	-$538.82K	-$1.78M
EPS Diluted	-$0.02	-$0.01	-$0.01	-$0.03

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Biolargo, Inc. · CIK 880242 · Engraved from SEC EDGAR